GE HealthCare introduces next-level LOGIQ ultrasound systems, driving improved everyday performance and smarter clinical insights

• Newest generation of LOGIQ systems delivers powerful, comprehensive tools for whole‑body imaging, including enhanced liver assessment and improved patient management
• New Auto Abdominal Suite 2.0 for faster, more consistent imaging and improved exam efficiency
• Expanded open platform integrates a growing ecosystem of third-party ultrasound solutions –enabling smarter workflows and more connected, collaborative, patient-centered care

GE HealthCare (Nasdaq: GEHC) today announced the next generation of LOGIQ™ general imaging ultrasound systems – an intelligently designed portfolio built to elevate clinical imaging, accelerate workflows, and unlock deeper diagnostic insight. Equipped with advanced imaging capabilities, enhanced AI-powered automation, and an expanded open digital platform, the latest LOGIQ systems are engineered to simplify daily practice while supporting more confident, informed clinical decisions. GE HealthCare will showcase the new LOGIQ E10 Series, LOGIQ Fortis™, and LOGIQ Totus™—all featuring Verisound™ Digital and AI innovations—at the European Congress of Radiology 2026 in Vienna, March 4–7, 2026.

As imaging volumes continue to rise and clinicians face mounting time and resource pressures, there is a demand for ultrasound technology that accelerates diagnosis, especially in environments constrained by time and resources. For more than 30 years, LOGIQ ultrasound systems have continually evolved, integrating advanced solutions designed to help clinicians meet today’s challenges and adapt to what comes next in full body ultrasound.

“Meeting the demands of modern healthcare requires forward-thinking innovation, and redefining what ultrasound can deliver—today and into the future—is central to that mission,” said Karley Yoder, CEO, Comprehensive Care Ultrasound (CCU), Advanced Visualization Solutions, GE HealthCare. “LOGIQ ultrasound systems are built to raise the standard of diagnostic confidence, productivity and precision across a wide range of clinical applications—from routine exams to complex abdominal and liver assessment—helping clinicians move from image acquisition to clinical insight faster while seamlessly evolving with next-generation technologies to meaningfully improve patient care.”

To support imaging across a broad range of applications, the newest LOGIQ portfolio introduces advanced imaging capabilities, enhancing clinical confidence across a variety of care areas, and expanded transducers, including specialty and multi-purpose probes and the wireless Vscan Air™, delivering exceptional image quality and diagnostic precision.

Liver diseases represent a significant portion of the global disease burden with the prevalence of fatty liver disease increasing significantly over the last three decades.^[i] Nearly 40% of the global population is affected by fatty liver disease but it remains underdiagnosed and untreated, making early and reliable assessments increasingly important for disease management^.[i],[ii]  As a widely available and familiar modality, ultrasound plays a key role in identifying liver changes and guiding next steps in management.^[iii] The enhanced LOGIQ portfolio is designed to strengthen liver evaluations with new clinical tools such as Ultrasound-Guided Fat Fraction (UGFF), enabling more consistent assessment of liver fat burden. UGFF supports clinicians in monitoring disease progression and assisting in determining severity to inform earlier intervention and more personalized care, particularly for individuals living with metabolic dysfunction–associated fatty liver disease.

“Clinicians need solutions that remove complexity and enable them to perform at their best every day,” said Sally Lee, General Manager, General Imaging, Primary Care and Automated Breast Ultrasound (ABUS), CCU, GE HealthCare. “The latest LOGIQ systems combine advanced imaging with comprehensive tools and AI-driven innovation for a next-level ultrasound experience—elevating efficiency, streamlining system interactions and empowering confident clinical decisions.”

To further accelerate clinical workflows, new AI-powered tools help detect and segment anatomy, enhance measurement accuracy, and reduce system interactions. New tools such as Auto Abdominal Suite 2.0* with SmartEdit capabilities add Auto Abdominal Color Assistant 2.0, Auto Aorta Measure Assistant, and Auto CBD Measure Assistant. When combined with Scan Assistant, these tools have supported 65% faster measurements and 80% fewer system interactions, helping standardize exams and boost productivity through intelligent anatomical recognition.^[iv]

The expansion of the LOGIQ open digital platform unlocks new system potential by enabling seamless integration of third-party applications alongside Verisound Digital offerings. This platform delivers streamlined access to AI tools and integrated on-scanner ViewPoint™  reporting**—supporting more connected workflows, personalized system customization, and consistent, data-driven decision-making and reporting.

Together, these capabilities reinforce GE HealthCare’s commitment to elevating LOGIQ’s full-body imaging performance—empowering clinicians with intelligently designed tools, smarter workflows, and a connected, future-ready platform.

The latest LOGIQ ultrasound systems are 510(k) cleared and CE Marked. These ultrasound systems are available in other markets where regulatory approval has been granted. For more information on the LOGIQ portfolio, visit: https://www.gehealthcare.com/products/ultrasound/logiq.

*Auto Abdominal Suite 2.0 is available on the LOGIQ E10 Series and LOGIQ Fortis. LOGIQ Totus includes Auto Abdominal Color Assistant 1.0, Auto Preset Assistant, and the new Auto Renal Measure Assistant, reflecting the feature set of Auto Abdominal Suite 1.0.

**On-scanner capability is available with ViewPoint Ultra, version 1.0 exclusively on LOGIQ R5 systems. Commercial availability is currently limited to the United States.

[i] Wong, Vincent Wai‑Sun, Mattias Ekstedt, Grace Lai‑Hung Wong, and Hannes Hagström. “Changing Epidemiology, Global Trends and Implications for Outcomes of NAFLD.” Journal of Hepatology 79, no. 3 (2023): 842–852. https://doi.org/10.1016/j.jhep.2023.04.036.

[ii] Klein, Hayden E. “Alarming Rise in Liver Disease Amid Global Fatty Liver Day 2025.” American Journal of Managed Care, June 12, 2025. https://www.ajmc.com/view/alarming-rise-in-liver-disease-amid-global-fatty-liver-day-2025.

[iii] Maruyama, H., & Kato, N. (2019). Advances in ultrasound diagnosis in chronic liver diseases. Clinical and Molecular Hepatology, 25(2), 160–167. https://doi.org/10.3350/cmh.2018.1013

[iv] Claims based on GE HealthCare LOGIQ ultrasound AI and automation claims evaluation study. Conducted June 2025. DOC3073348.